Quality of life issues in patients dying from haematological diseases.
Quality of life issues in patients dying from haematological diseases.
复制标题
死于血液疾病的患者的生活质量问题。
DOI：
--
复制
发表时间：
1994
期刊：
影响因子：
--
通讯作者：
J. Sheedy
中科院分区：
文献类型：
--
作者：
I. Maddocks;L. Bentley;J. Sheedy
在南澳大利亚，患有血液疾病的患者无法立即获得临终关怀服务。他们与血液科或肿瘤科专家保持密切联系，并且比实体瘤患者更有可能在临终住院期间接受强化治疗。通过查阅医院记录，对三组患有结直肠癌、非霍奇金淋巴瘤和急性白血病的患者的生命最后一个月的病程进行了比较。所有白血病患者均在医院死亡，很少有人接受姑息治疗咨询。没有记录这些患者的症状控制和生活质量的测量结果。患有急性白血病的成年人很可能会继续在医院死亡。从临终关怀实践中吸取的一些经验教训可以适当地应用于医院中的这些患者。
Patients with haematological diseases do not have ready access to hospice services in South Australia. They remain in close contact with a specialist haematology or oncology unit, and are more likely than are patients with solid tumours to receive intensive therapy during a terminal admission. The course of the final month of life was compared for three groups of patients suffering from colorectal cancer, non-Hodgkins lymphoma and acute leukaemia by a review of hospital records. All leukaemia patients died in hospital and few received a palliative care consultation. Measures of symptom control and quality of life are not recorded for these patients. It seems probable that adults with acute leukaemia will continue to die in hospital. Some of the lessons learnt from hospice practice may be appropriately applied in hospital for those patients.